Quick Takeaways
- Wildcat Capital Management, LLC filed SCHEDULE 13D/A for Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share (SLXN).
- Disclosed ownership: 1.3%.
- Date of event: 26 Jun 2025.
Wildcat Capital Management, LLC - 26 Jun 2025 SCHEDULE 13D/A Report for Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share (SLXN)
- Filing Manager
- Wildcat Capital Management, LLC
- Reporting Manager
- Wildcat Capital Management, LLC
- Symbol
- SLXN
- Shares outstanding
- 8,725,231 shares
- Disclosed Ownership
- 113,428 shares
- Ownership
- 1.3%
- Form type
- SCHEDULE 13D/A
- Filing time
- 26 Jun 2025, 16:15:38 UTC
- Date of event
- 26 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Wildcat Capital Management, LLC disclosed 1.3% ownership in Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share (SLXN) on 26 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 26 Jun 2025, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Wildcat Capital Management, LLC | 1.3% | 113,428 | 0 | 113,428 | /s/Leonard A. Potter | Leonard A. Potter/President | 0001582384 |
| Wildcat Partner Holdings, LP | 1.3% | 113,428 | 0 | 113,428 | /s/Sherri Conn | Sherri Conn/Vice President | 0001633223 |
| Leonard A. Potter | 1.3% | 113,428 | 0 | 113,428 | /s/Leonard A. Potter | Leonard A. Potter | 0001476217 |